Immunomodulation Effect of Blood Transfusion
Allogeneic Red Cell Transfusion and Its Influence on Relevant Humoral and Cellular Immunological Parameters
Sponsor: Mahidol University
A observational or N/A phase clinical study on Immune Defect and Incompatible Blood Transfusion, this trial is completed. The trial is conducted by Mahidol University and has accumulated 13 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jul 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Jul 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mahidol University
- Wolf Schleinzer Stiftung zur Wissenschafts- und Bildungsförderung, Germany
For direct contact, visit the study record on ClinicalTrials.gov .